Spatial distribution of granzyme B to improve the predictive power of response to immunotherapy in operable lung cancer

被引：0
|
作者：
Ramos, Corinne [1 ]
Lemieux, Ophelie [1 ]
Ponzoni, Adele [1 ]
Stauber, Jonathan [1 ]
机构：
[1] ImaBiotech, Billerica, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1116
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Towards predictive biomarkers for immunotherapy response in breast cancer patients
    Voorwerk, Leonie
    Kat, Marije
    Kok, Marleen
    BREAST CANCER MANAGEMENT, 2018, 7 (01)
  • [32] Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
    Raimondi, Alessandra
    Sepe, Pierangela
    Zattarin, Emma
    Mennitto, Alessia
    Stellato, Marco
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    de Braud, Filippo
    Procopio, Giuseppe
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response
    Kim, Joon
    Yong, Seung Hyun
    Jang, Gyuho
    Kim, Yumin
    Park, Raekil
    Koh, Hyun-Hee
    Kim, Sehui
    Oh, Chang-Myung
    Lee, Sang Hoon
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [34] Multiomic dissection of immunotherapy response groups in lung cancer
    Kulasinghe, Arutha
    RESPIROLOGY, 2023, 28 : 24 - 24
  • [35] The impact of BMI on the response to immunotherapy in lung cancer.
    Ying, Yuan
    Gujju, Veena
    Hallum, Gideon
    Shikdar, Sufana
    Vesely, Sara
    Hall, Spencer
    Ayanambakkam, Adanma
    Aljumaily, Raid
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Genomic Features of Response to Combination Immunotherapy in Lung Cancer
    Frueh, Martin
    Peters, Solange
    CANCER CELL, 2018, 33 (05) : 791 - 793
  • [37] Thyroid toxicity as predictor of response to immunotherapy in lung cancer
    Kazanietz, V.
    Cayol, F.
    Cerini, M.
    Storino, J.
    Specterman, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S725 - S725
  • [38] Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)
    Decoster, L.
    Nazari, S.
    De Ridder, K.
    Giron, P.
    Vekens, K.
    Goyvaerts, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1052 - S1052
  • [39] Are KRAS Mutations Predictive of Response to Immunotherapy in Non Small-Cell Lung Cancer? A Single Center Experience
    Friedlaender, A.
    Torralvo, J.
    Dietrich, P.
    Addeo, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S666 - S666
  • [40] Neutrophil-Lymphocyte Ratio: A Predictive Biomarker of Immunotherapy in Lung Cancer?
    Mendes, M.
    China, N.
    Reis, D.
    Campainha, S.
    Dias, M.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S464 - S465
12345